Table 1 Modulation of IC molecules in the TME by radiotherapy.
From: Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
IC molecules | Cell types | Changes | Cancer species | RT | Reference |
|---|---|---|---|---|---|
PD-1 | CD8+ T cells | ↓ | Pancreatic cancer | 5 Gy × 5 | [117] |
TAMs | ↓ | Rectal cancer | 2 Gy | [109] | |
CD4+ T cells CD8+ T cells | ↑ | Lung cancer | 10 Gy × 4 | [30] | |
CD4+ T cells CD8+ T cells | ↑ | Gastric cancer | 5 Gy × 3 | [79] | |
T cells | ↑ | Prostate cancer | 6 Gy | [75] | |
PD-L1 | Tumor cells | ↑ | Pancreatic cancer | 5 Gy × 5 | [117] |
Tumor cells | ↑ | Prostate cancer | 6 Gy | [75] | |
Tumor cells | ↑ | Colon cancer | 8 Gy × 3 | [120] | |
Tumor cells | ↑ | Melanoma | 2 Gy × 4 | [118] | |
Tumor cells | ↑ | Lung cancer | 10 Gy × 4 | [30] | |
|  |  |  | 20 Gy | [15] | |
Tumor cells | ↑ | Gastric cancer | 5 Gy × 3 | [79] | |
Tumor cells | ↑ | Cervical squamous carcinoma | 10 Gy | [121] | |
Tumor cells | ↑ | Breast cancer | 8 Gy × 3 | [15] | |
|  |  |  | 12 Gy | [86] | |
TILs | ↑ | Melanoma | 2 Gy × 4 | [118] | |
CD4+ T cells CD8+ T cells | ↑ | Lung cancer | 10 Gy × 4 | [30] | |
CD8+ T cells | ↑ | HNSCC | 10 Gy | [122] | |
DCs | ↑ | Lung cancer | 10 Gy × 4 | [30] | |
DCs | ↑ | Breast cancer | 12 Gy | [86] | |
MDSCs | ↑ | Lung cancer | 10 Gy × 4 | [30] | |
Macrophages | ↑ | Breast cancer | 12 Gy | [86] | |
CTLA-4 | iTregs | ↓ | N/A | 10 Gy | [40] |
TIGIT | CD8+ T cells | ↓ | Colon cancer | 2 Gy × 18 | [120] |
CD3+CD4+ T cells CD3+CD8+ T cells | ↓ | OAC | 2 Gy, 4 Gy | [127] | |
CD8+ T cells | ↑ | Colon cancer | 8 Gy × 3 | [120] | |
TIM-3 | CD3+CD4+ T cells CD3+CD8+ T cells | ↓ | OAC | 2 Gy, 4 Gy | [127] |
NK cells | ↑ | Lung and liver cancer | Median: 10 Gy × 5 | [31] | |
CD8+ T cells | ↑ | HNSCC | 10 Gy | [122] | |
Tregs | ↑ | HNSCC | 10 Gy | [122] | |
LAG-3 | iTregs | ↑ | N/A | 10 Gy | [40] |